MedPath

Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus

Not Applicable
Completed
Conditions
Lichen Planus, Oral
Interventions
Biological: buccal cavity sample
Registration Number
NCT02276573
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

Oral lichen planus (OLP) is a chronic inflammatory and relapsing. The average prevalence is 1 to 4%. The clinics forms are many and symptoms are varied. The erosive form, painful and debilitating is characterized by erosive areas, ulcerated on an erythematous base with or without a keratinocyte lichenien network.

The literature data moving towards an autoimmune origin, but the pathophysiological mechanisms of OLP remain unknown.

This project represents the first part of a comprehensive project to examine the oral pathogenesis of different viruses (Herpes and papillomavirus HPV) and centered on Epstein-Barr Virus (EBV).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13
Inclusion Criteria
  • Patient ≥ 18 years
  • Clinical and/or histological diagnosis of erosive or atrophic OLP
  • No signs of severe dysplasia at the sampling
Exclusion Criteria

o immunosuppressive or anti-inflammatory therapies at the inclusion

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Oral lichen planus diseasebuccal cavity samplebuccal cavity sample
Primary Outcome Measures
NameTimeMethod
Measure of level of EBV nucleic acidsday 1
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hôpital saint Roch

🇫🇷

Nice, France

© Copyright 2025. All Rights Reserved by MedPath